This $15 million Seresto settlement resolved claims about flea-and-tick collar marketing and alleged pet harm. Final approval was granted in January 2025, benefits were distributed, and a later fee dispute did not reopen consumer claims.
Current Status
This settlement is complete. Claims closed July 23, 2024, final approval was entered January 6, 2025, and the administrator expected benefits in early May 2025. A June 2026 federal appellate decision concerning attorneys' fee allocation states that settlement funds had already been distributed; it did not reopen the consumer claim period.
What Was the Lawsuit About?
The multidistrict litigation involved claims about the marketing, sales practices, and alleged product-liability risks of Seresto flea and tick collars. Plaintiffs alleged that collars sold for cats and dogs did not perform as represented and were associated with injuries or deaths in some pets.
Bayer- and Elanco-related defendants denied the claims and denied violating the law. The court did not decide the underlying allegations at trial; the parties established a $15 million settlement fund to resolve them.
Who Was Included?
The settlement class included people in the United States, its territories, and the District of Columbia who purchased a Seresto product for personal use, rather than resale, on or before July 8, 2024. A class member had to submit a valid claim by July 23, 2024 to receive a cash benefit.
What Benefits Were Available?
The settlement offered several claim categories:
- Collar reimbursement of $13 per purchased collar, with proof supporting the number claimed and a limited no-documentation option.
- A $25 payment for alleged economic injury to a pet, supported by the required declaration, or reimbursement of documented out-of-pocket veterinary treatment costs.
- A $300 payment for an alleged pet death, supported by the required declaration, plus reimbursement of documented burial, cremation, or similar disposal costs where allowed.
A claimant could qualify for more than one category when the claim form and documentation supported each requested benefit.
What Proof Was Required?
Proof depended on the category. Purchase records supported collar reimbursement beyond the limited no-proof allowance. Veterinary invoices or other records were required for reimbursement of treatment expenses, and death-related expense reimbursement required corresponding documentation. The declaration-based injury and death payments required the claimant to attest to the alleged event.
Because some tiers required documents or declarations, the settlement should not be described simply as “no proof required.”
What Happened After Final Approval?
The court held the fairness hearing on January 3, 2025 and entered final approval on January 6, 2025. The official FAQ later said claims processing was in its final stages and benefits were expected in early May 2025.
A separate dispute over how attorneys' fees were allocated produced a 2026 appellate opinion. The appeals court affirmed the ruling in that fee dispute and recorded that class counsel reported the settlement funds had already been distributed. The dispute did not concern whether consumers could submit new claims.
Why Can't I File Now?
The claim deadline passed more than two years ago and the settlement fund was distributed. Old submission links and paper forms are historical only. A claimant with a question about a payment already issued should use the official settlement website rather than attempting to create a new claim.
Sources
- Official Seresto Settlement website
- Official final approval order and case documents
- June 2026 Seventh Circuit fee-allocation decision
